1. Home
  2. MAGN vs LXRX Comparison

MAGN vs LXRX Comparison

Compare MAGN & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Magnera Corporation

MAGN

Magnera Corporation

HOLD

Current Price

$13.38

Market Cap

465.3M

ML Signal

HOLD

LXRX

Lexicon Pharmaceuticals Inc.

HOLD

Current Price

$1.26

Market Cap

465.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MAGN
LXRX
Founded
1864
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Paper
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
465.3M
465.2M
IPO Year
N/A
2000

Fundamental Metrics

Financial Performance
Metric
MAGN
LXRX
Price
$13.38
$1.26
Analyst Decision
Buy
Buy
Analyst Count
1
5
Target Price
$18.00
$3.23
AVG Volume (30 Days)
492.3K
3.5M
Earning Date
02-05-2026
03-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,204,000,000.00
$70,864,000.00
Revenue This Year
$5.74
$56.61
Revenue Next Year
$2.51
N/A
P/E Ratio
N/A
N/A
Revenue Growth
46.50
1255.21
52 Week Low
$7.82
$0.28
52 Week High
$23.19
$1.83

Technical Indicators

Market Signals
Indicator
MAGN
LXRX
Relative Strength Index (RSI) 43.36 45.95
Support Level $12.65 $1.10
Resistance Level $13.98 $1.83
Average True Range (ATR) 0.57 0.16
MACD -0.15 -0.03
Stochastic Oscillator 28.56 21.92

Price Performance

Historical Comparison
MAGN
LXRX

About MAGN Magnera Corporation

Magnera Corp is a supplier of a diverse portfolio of specialty materials comprised of organic and synthetic raw ingredients. The company markets its own products predominantly into stable, consumer-oriented end markets, including wipes, healthcare, adult incontinence, apparel, baby, feminine care, air filtration, and food and beverage, for disposable and durable applications. It also provides technical solutions in infrastructure markets. The company's operations are organized into two operating and reportable segments: Americas and Rest of World. It derives the majority of its revenue from the Americas, which manufactures products and components of personal care, including medical garments, wipes, dryer sheets, filtration, baby diapers and adult incontinence.

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.

Share on Social Networks: